Enhertu with Pertuzumab approved in China for 1L HER2-positive metastatic Breast cancer

Hengrui’s Aiweida receives NMPA approval for HER2-positive Colorectal cancer

AbbVie’s Elahere receives Minzdrav approval in Russia for Ovarian, Fallopian tube and Peritoneal cancer

Celltrion’s CT-P73 receives US FDA FTD for recurrent/metastatic Cervical cancer

ITM receives Complete Response Letter for ITM-11

Asieris received FDA IND approval for APL 2501 for the treatment of advanced Solid tumors